FIELD: bioengineering.
SUBSTANCE: method of inhibition of metastasis G-CSF of secrete primary tumour in vivo is suggested. The individual is injected with effective number of antibodies against G-CSF or its antigen-binding fragment after removal of the primary tumour.
EFFECT: invention use ensures new method of inhibition of metastasis G-CSF of secrete primary tumour, this can be used in therapy of tumours.
7 cl, 16 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANGIOGENESIS INHIBITION | 2008 |
|
RU2471498C2 |
| ANTI-BV8 ANTIBODIES AND USING THEM | 2010 |
|
RU2559542C2 |
| COMBINED THERAPY WITH USING ALPHA5BETA1 ANTAGONISTS | 2007 |
|
RU2465282C2 |
| COMBINED METHODS FOR TREATING WITH PD-L1 ANTAGONISTS | 2016 |
|
RU2766890C2 |
| NOVEL ANTIBODIES | 2008 |
|
RU2490277C2 |
| METHODS OF TREATING CANCER USING PD-1 AXIS BINDING AND VEGF ANTAGONISTS | 2013 |
|
RU2689760C2 |
| ANGIOPOIETIC ANGIOPOIETIN-LIKE PROTEIN 4 INHIBITORS, IN COMBINATIONS AND APPLICATION | 2005 |
|
RU2392966C2 |
| ANTIBODIES AGAINST AXL AND THEIR APPLICATION | 2011 |
|
RU2577986C2 |
| HYBRID PROTEINS BASED ON HUMAN Notch3 AS TRAPS-INHIBITORS OF Notch3 SIGNAL TRANSMISSION | 2009 |
|
RU2567662C2 |
| COMPOSITIONS OF HUMANISED NOTCH FUSED PROTEINS AND METHODS OF TREATING | 2008 |
|
RU2532830C2 |
